登录 | 注册    关注公众号  
微信公众号
搜索
 > 【Klotho beta】

Klotho beta信息

英文名称:Klotho beta
中文名称:Klotho β蛋白
靶点别称:Klotho Beta,Klotho Beta-Like Protein,B-Klotho,Klotho Beta Like,Beta-Klotho,EC 3.2.1,BKL,BetaKlotho,KLB
上市药物数量:0
临床药物数量:3
最高研发阶段:临床二期

Klotho beta分子别名

betaKlotho,beta-klotho,BKL,KLB,klotho beta like,klotho beta-like protein

Klotho beta分子背景

KLB (Klotho Beta) is a Protein Coding gene. Among its related pathways are RET signaling and HIV Life Cycle. GO annotations related to this gene include hydrolase activity, hydrolyzing O-glycosyl compounds and fibroblast growth factor binding. An important paralog of this gene is KL. Klotho Beta is a regulator in multiple metabolic processes, while its role in cancer remains unclear. We found the expression of βKlotho was down-regulated in human hepatocellular carcinoma tissues compared with that in paired adjacent non-tumourous liver tissues. Hepatoma cells also showed decreased expression of βKlotho compared with normal hepatocyte cells. Reintroduction of βKlotho into hepatoma cells inhibited their proliferation.

Klotho beta临床药物信息

英文名称 研发代码 研发阶段 公司 适应症 临床试验
NGM-313 NGM-313; MK-3655 临床二期 Ngm Biopharmaceuticals Inc 非酒精性脂肪性肝炎, 肝炎, 肥胖症 详情
Fazpilodemab RG-7992; BFKB-8488A; RO-7040551 临床一期 基因泰克 非酒精性脂肪性肝炎, 二型糖尿病, 胰岛素抵抗 详情
B-1344 B-1344 临床一期 天士力生物医药股份有限公司 非酒精性脂肪性肝炎, 二型糖尿病 详情

消息提示

请输入您的联系方式,再点击提交!

确定